Institutional Strategic Support Fund Phase2 FY2014/16 (360G-Wellcome-105630_Z_14_Z)

The Institutional Strategic Support Fund (ISSF) is co-funded by The Wellcome Trust and strategic support from the University for the Genome Damage and Stability Centre and the Translational Drug Discovery Group. The ISSF supports our Vision for Translational Biomedical Research in three main ways : Translational Platform: supporting the establishment and operation of the multidisciplinary early-stage translational platform, by co-funding core posts and consumables. Pilot Fund: providing an opportunistic pilot fund to support exploratory studies to enable new targets arising from discovery science projects across the University and Medical School, to access key resources required to bridge from discovery to translational science to enable both strong clinical target validation and entry into the drug discovery pipeline. Public Engagement : supporting Public Engagement and Widening Participation activities to inform and educate the public on the ways that we are translating basic discovery research to real impact in the diagnosis and treatment of major human diseases, and to encourage and support students from less privileged backgrounds to enter careers in translational science.